N-of-One to Provide Clinical Interpretation Support for Molecular Diagnostics Program [News]
N-of-One Announces Agreement with Mayo Clinic to Provide Clinical Interpretation Support for Molecular Diagnostics Program
LEXINGTON, Mass., May 21, 2014 – N-of-One, the leading provider of clinical interpretation for precision medicine in oncology, today announced an agreement with Mayo Clinic to provide access to clinical interpretation information to aid in highly complex molecular diagnostics.
Under the terms of the agreement, in select cases, N-of-One solutions will assist in the identification of biological and clinical knowledge, therapeutic options, and potential clinical trials for patients who undergo next generation cancer sequencing. This will help to translate state-of-the-art knowledge specifically related to individual patients’ tumors into molecularly informed, personalized treatment decisions. Mayo Clinic will use the clinical interpretation services for Mayo Medical Laboratories, a global reference laboratory operating within Mayo Clinic’s Department of Laboratory Medicine and Pathology, as well as in its Center for Individualized Medicine, which discovers and integrates the latest in genomic, molecular and clinical sciences into personalized care for each Mayo Clinic patient.
“The N-of-One team is pleased to work with the talented physicians and geneticists at Mayo Clinic,” said Chris Cournoyer, CEO of N-of-One. “With the rapidly increasing volume of clinical and scientific data, and hundreds of drugs currently in clinical trials, the task of interpreting molecular test results has become increasingly challenging. We are committed to providing scalable, cost effective genomic clinical decision support that delivers valuable analysis and interpretation of the relevant clinical data to support oncologists in making molecularly informed treatment decisions for their patients.”
About Mayo Clinic
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.org/ and newsnetwork.mayoclinic.org.
N-of-One, a leader in precision medicine for oncology, leverages its world-class team of experts to translate molecular data specific to each patient into state-of-the-art, clinical insights and therapeutic options. N-of-One’s team of experts has interpreted more than 7,000 tumors for oncologists and patients worldwide, through partnerships to provide clinical interpretation for leading diagnostic companies (such as Foundation Medicine and Clarient), through agreements with provider networks (such as Fox Chase Cancer Center in Philadelphia), directly to oncologists and through employee access benefit programs (such as Life Technologies). N-of-One does not provide medical advice or promote any product or service. For more information, please visit www.n-of-one.com or call 617-202-9808.